Kmc Speciality Hospitals India Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 04, 2026

Key Highlights

The Latest Trading Price of KMC Speciality Hospitals (India) Ltd is ₹ 83.69 as of 02 Apr 15:30 . The P/E Ratio of KMC Speciality Hospitals (India) Ltd changed from 28 on March 2021 to 46.9 on March 2025 . This represents a CAGR of 10.87% over 5 yearsThe P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 55.9 on March 2021 to 194.2 on March 2025 . This represents a CAGR of 28.28% over 5 years The Market Cap of KMC Speciality Hospitals (India) Ltd changed from ₹ 355.56 crore on March 2021 to ₹ 1001 crore on March 2025 . This represents a CAGR of 23.01% over 5 yearsThe Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 87.14 crore on March 2021 to ₹ 145.37 crore on March 2025 . This represents a CAGR of 10.78% over 5 years The revenue of KMC Speciality Hospitals (India) Ltd for the Dec '25 is ₹ 83.19 crore as compare to the Sep '25 revenue of ₹ 76.15 crore. This represent the growth of 9.24% The revenue of Lotus Eye Hospital & Institute Ltd for the Dec '25 is ₹ 13.79 crore as compare to the Sep '25 revenue of ₹ 13.31 crore. This represent the growth of 3.61% The ebitda of KMC Speciality Hospitals (India) Ltd for the Dec '25 is ₹ 25.88 crore as compare to the Sep '25 ebitda of ₹ 22.09 crore. This represent the growth of 17.16% The ebitda of Lotus Eye Hospital & Institute Ltd for the Dec '25 is ₹ 0.89 crore as compare to the Sep '25 ebitda of ₹ 1.04 crore. This represent the decline of -14.42% The net profit of KMC Speciality Hospitals (India) Ltd changed from ₹ 5.51 crore to ₹ 13.73 crore over 7 quarters. This represents a CAGR of 68.49% The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0.62 crore to ₹ -0.26 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of KMC Speciality Hospitals (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About KMC Speciality Hospitals (India) Ltd

KMC Speciality Hospitals (India) Limited was originally incorporated as 'Advanced Medical Care Private Limited' on December 31, 1982 and was converted into a Public Limited Company on July 15, 1988.
The name of the Company was changed to 'Seahorse Hospitals Limited' on March 21, 1995 and to its current name 'KMC Speciality Hospitals (India) Limited' with effect from October 24, 2008. The Company is a part of the KMC Group of Hospitals based at Tiruchirappalli.
The Company is a super speciality hospital based in Trichy, belonging to the Kauvery Hospitals Group.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It provide quality healthcare to patients in key specialty areas such as Neurosurgery, Cardiovascular & thoracic surgery, Orthopedics, Plastic and Reconstructive Surgery, Gynecology, Neonatology and Nephrology (including renal transplants).

About Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
Limited' on 14 March, 1997.
The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.

FAQs for the comparison of KMC Speciality Hospitals (India) Ltd and Lotus Eye Hospital & Institute Ltd

Which company has a larger market capitalization, KMC Speciality Hospitals (India) Ltd or Lotus Eye Hospital & Institute Ltd?

Market cap of KMC Speciality Hospitals (India) Ltd is 1,364 Cr while Market cap of Lotus Eye Hospital & Institute Ltd is 209 Cr

What are the key factors driving the stock performance of KMC Speciality Hospitals (India) Ltd and Lotus Eye Hospital & Institute Ltd?

The stock performance of KMC Speciality Hospitals (India) Ltd and Lotus Eye Hospital & Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KMC Speciality Hospitals (India) Ltd and Lotus Eye Hospital & Institute Ltd?

As of April 4, 2026, the KMC Speciality Hospitals (India) Ltd stock price is INR ₹83.69. On the other hand, Lotus Eye Hospital & Institute Ltd stock price is INR ₹100.65.

How do dividend payouts of KMC Speciality Hospitals (India) Ltd and Lotus Eye Hospital & Institute Ltd compare?

To compare the dividend payouts of KMC Speciality Hospitals (India) Ltd and Lotus Eye Hospital & Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.